Objective: Obesity and social anxiety disorders (SADs) are prevalent conditions that significantly impact individuals’ quality of life. Understanding the relationship between these conditions is crucial for effective healthcare interventions. This study aimed to investigate the presence of SADs among obese and non-obese individuals aged 18-45 years and assess their impact on quality of life.
Methods: Participants were evaluated using a sociodemographic information form and the Liebowitz social anxiety scale (LSAS). Measurements of height, body mass, hip circumference (HC), and waist circumference (WC) were also performed to assess obesity status.
Results: Analysis revealed that as body mass index increased, LSAS scores significantly increased (p=0.008, r=0.223), indicating a strong correlation between obesity and social anxiety levels. Among the obese and non-obese groups, obese participants showed a significantly higher likelihood of having SAD [Liebowitz social anxiety disorder (LSAD)] (p=0.026). This trend was particularly pronounced among women; obese females had significantly higher LSAD scores than non-obese females (p=0.023). Furthermore, LSAD scores significantly increased with waist and HCs (p=0.018, p=0.031, respectively), with a notable gender difference where increased WC was associated with higher LSAD scores in women (p=0.035).
Conclusion: The findings underscore the importance of psychological support in obesity treatment and advocate for comprehensive psychiatric evaluations for all patients. Addressing gender-specific challenges through targeted interventions could improve overall mental and physical health outcomes. Incorporating psychological support is vital for achieving sustained weight loss and enhancing quality of life. This study highlights the integral role of mental health support in treating obesity, emphasizing the need for gender-specific approaches to address the intertwined issues of obesity and social anxiety. A multidisciplinary strategy that includes psychological care is essential for effective treatment and long-term success.